Menard Financial Group LLC Invitae Corp Transaction History

Menard Financial Group LLC

  • $146 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 17, 2021
SELL
$33.06 - $56.93 $269,835 - $464,662
-8,162 Closed
0 $0
Q4 2020

Feb 09, 2021
BUY
$39.09 - $57.4 $23,414 - $34,382
599 Added 7.92%
8,162 $341,000
Q3 2020

Nov 12, 2020
BUY
$28.43 - $44.67 $215,016 - $337,839
7,563 New
7,563 $328,000

Others Institutions Holding NVTA

# of Institutions
20
Shares Held
1.92M
Call Options Held
0
Put Options Held
0
View Full List

About Invitae Corp

NVTA Quotes by TradingView
  • Ticker NVTA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 235,266,000
  • Description
  • Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...
More about NVTA
Track This Portfolio

Track Menard Financial Group LLC Portfolio

Follow Menard Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Menard Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Menard Financial Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email